Dr. Martin on Selinexor in Triple-Class Refractory Multiple Myeloma Thomas G. Martin, MD, clinical professor of medicine, Adult Leukemia and Bone Marrow Transplantation Program, associate director, Myeloma Program, University of California, San Francisco, and co-leader, Hematopoietic Malignancies Program, Helen Diller Family Comprehensive Cancer Center, discusses the use of selinexor in patients with triple-class refractory multiple […]

Read More